Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced CancerJulie R. Brahmer, Jon M. Wigginton, Scott S. Tykodi et al.|New England Journal of Medicine|2012Cited by 8k
Intraepithelial CD8 <sup>+</sup> tumor-infiltrating lymphocytes and a high CD8 <sup>+</sup> /regulatory T cell ratio are associated with favorable prognosis in ovarian cancerEiichi Sato, Kunle Odunsi, Sara H. Olson et al.|Proceedings of the National Academy of Sciences|2005Cited by 2.4k
Tumor-infiltrating NY-ESO-1–specific CD8 <sup>+</sup> T cells are negatively regulated by LAG-3 and PD-1 in human ovarian cancerJunko Matsuzaki, Kunle Odunsi, Cheryl Eppolito et al.|Proceedings of the National Academy of Sciences|2010Cited by 844
Association of Type and Location of<i>BRCA1</i>and<i>BRCA2</i>Mutations With Risk of Breast and Ovarian CancerTimothy R. Rebbeck, Saundra S. Buys, Nandita Mitra et al.|JAMA|2015Cited by 507
Germline Mutations in the BRIP1, BARD1, PALB2, and NBN Genes in Women With Ovarian CancerSusan J. Ramus, Simon A. Gayther, Honglin Song et al.|JNCI Journal of the National Cancer Institute|2015Cited by 441